Other Relevant Articles - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series
ACC Clinical Bulletin Focuses on Cardiac Implications of Coronavirus (COVID-19)
CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Hemodynamic Response to Nitroprusside in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Ejection Fraction
Inflammation: A New Target For CAD Treatment and Prevention
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
Cardiopulmonary Exercise Testing: What Is its Value?
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association

|<< 1 2 3 4 5 6 7 ...>>|

Original Research

2018 Aug 27.

JOURNAL：N Engl J Med.

Article Link

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

Obadia JF, Messika-Zeitoun D, MITRA-FR Investigators et al.

15400

Keywords: chronic heart failure; reduced left ventricular ejection fraction; severe secondary mitral-valve regurgitation; percutaneous mitral-valve repair;clinical outcome

FULL TEXT PDF